Cyclobenzaprine Hydrochloride Tablet, Film Coated
Product Images NDC 69097-845

5 FDA label images from Cipla Usa Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 69097-845). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (7d5e3bad 7f85 4e2b 81c5 7981c456e45f 01)

Image (7d5e3bad 7f85 4e2b 81c5 7981c456e45f 01)
Chemical structure of cyclobenzaprine hydrochloride, showing its molecular framework with a three-ring system and attached functional groups, including the hydrochloride salt component.*
FDA Label Image

Image (7d5e3bad 7f85 4e2b 81c5 7981c456e45f 02)

Image (7d5e3bad 7f85 4e2b 81c5 7981c456e45f 02)
A data table showing percentages of adverse effects including drowsiness, dry mouth, fatigue, and headache among subjects taking Cyclobenzaprine HCl Tablets at 5 mg and 10 mg doses, compared with placebo. The table lists the number of subjects (N) in each group.*
FDA Label Image

Image (7d5e3bad 7f85 4e2b 81c5 7981c456e45f 03)

Image (7d5e3bad 7f85 4e2b 81c5 7981c456e45f 03)
Data table comparing the incidence of drowsiness, dry mouth, and dizziness during clinical studies and surveillance programs involving Cyclobenzaprine Hydrochloride 10 mg tablets. The table shows higher reported percentages of these side effects in clinical studies than in surveillance programs.*
FDA Label Image

Cyclobenzaprine 10 mg

Cyclobenzaprine   10 mg
Cyclobenzaprine Hydrochloride Tablets USP, 10 mg, film-coated oral tablets by Cipla USA Inc. The label indicates 100 tablets per container. It includes storage instructions, manufacturer details (InvaGen Pharmaceuticals, Inc.), and a barcode.*
FDA Label Image

Cyclobenzaprine 5 mg

Cyclobenzaprine   5 mg
Label for Cyclobenzaprine Hydrochloride Tablets USP 5 mg by Cipla USA Inc. The label indicates it is an oral, film-coated tablet product available in a 100-tablet package. It includes storage instructions, manufacturer information, a barcode, and dosage warning to see accompanying product information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.